Latest news

20 October 2026

Eni and Snam's Ravenna CCS selected for EU Innovation Fund

Multimodal CO₂ storage hub in the Adriatic secures 2025 Innovation Fund support; targets 4 Mtpa by 2030 with potential to expand to 16 Mtpa.
20 October 2026

Evonik launches stiffer VESTAKEEP PEEK dental grades DC4760 and DC4780

Two new dentin- and gingiva-colored PEEK grades offer higher stiffness, polishability and CAD/CAM compatibility for long-term metal-free dental prosthetics.
20 October 2026

Eni launches start-up of Meleiha Phase 2 in Egypt’s Western Desert

Start-up begins on Phase 2 facility to process up to 100 million scf/d, adding wells, gathering systems and a dedicated export pipeline to boost domestic gas supply.
20 October 2026

LANXESS launches Rely+On Medero disinfectant for the medical sector

Powder disinfectant effective vs bacteria, spores (incl. C. difficile), viruses, yeasts, fungi and mycobacteria; potassium monopersulfate + in‑situ chlorine; Class IIa device; sachets and bulk packs.
20 October 2026

EU–New Caledonia strategic partnership on sustainable raw materials

Covers value‑chain integration, sustainable nickel development, infrastructure, skills and R&I, and will be followed by a joint roadmap with Member States and the EIB.
20 October 2026

BASF expands Kuanyin site in Taiwan for sub‑2 nm semiconductor materials

Adds production capacity, boosts Innovation Center and analytical capabilities to support advanced nodes, improve supply‑chain resilience and speed customer support.
20 October 2026

BHP operational review for quarter ended 30 September 2026

Two fatalities at operations; copper output fell amid planned grade declines, maintenance and weather; Jansen Stage 1 is 87% complete and on track for mid‑2027 start; copper prices ~50% higher YoY.
20 October 2026

Asahi Kasei’s Tongsuh Petrochemical secures Reasonable Assurance PCF verification for acrylonitrile

Independent audit confirmed the fiscal‑2025 product carbon footprint for acrylonitrile at the Ulsan plant, covering raw materials through production and exceeding limited‑assurance standards.
19 October 2026

Takeda: VERDICT—ENTYVIO treat-to-target disease clearance delays first UC complication

Treating to corticosteroid-free disease clearance with vedolizumab lengthened time to first ulcerative colitis complication and cut complication risk by about 70%.
19 October 2026

Petrobras P-82 Platform Begins Voyage to Búzios Field

Left Singapore on 18/10 bound for the Búzios pre-salt field; part of the 80-series of six platforms with nominal 225,000 bpd and 12 million m³ gas compression capacity; start expected next year.
19 October 2026

EU adopts first union-wide mass balance rules — Perstorp endorses

EU sets harmonized mass balance accounting rules under the Single‑Use Plastics Directive, mandating chemical and site-level physical traceability, no overcompensation and fuel exclusions.
19 October 2026

BASF and HSCC explore 50:50 joint venture for European polyamide 6 value chain

Non-binding MoU to combine European PA6 value‑chain activities; possible inclusion of global extrusion outside North America; engineering plastics downstream businesses excluded.
19 October 2026

argenx presents Phase 3 ALKIVIA data showing efgartigimod benefits in autoimmune myositis

Phase 3 ALKIVIA shows clinically meaningful, rapid improvements in IMNM and dermatomyositis, seen by Week 4 and sustained to Week 52; primary endpoint met (TIS +15.4).
19 October 2026

Johnson & Johnson: TREMFYA sustains perianal fistula remission through 48 weeks in Phase 3 FUZION

In FUZION, TREMFYA 100 mg q8w combined remission rose from 28% at Week 24 to 35% at Week 48; 200 mg q4w rates remained stable and safety was consistent through one year.
19 October 2026

Koch Technology Solutions and Noventra sign PTA upgrade license for Port Qasim facility

License and Process Design Package will support selected PTA technology upgrades at Port Qasim to improve performance and energy efficiency, building on a 30-year partnership.
19 October 2026

INEOS launches LowINCO₂ low‑carbon olefins and polymers

New LowINCO₂ range offers product carbon footprints up to half the European industry average and helps customers cut Scope 3 emissions.
19 October 2026

Trafigura: Metals supply chains are becoming more connected

Demand diversification, new industries and above‑ground constraints are driving cross‑border metals trade; Trafigura has deployed $7bn and invested in power, rail, storage and processing.
19 October 2026

GSK’s Jemperli approved by FDA for MSI‑H/dMMR stage II–III locally advanced rectal cancer

First FDA‑approved immunotherapy for this biomarker-defined rectal cancer; AZUR-1 shows high sustained clinical complete response rates and no recurrences among responders.
19 October 2026

BASF wins EPA registration for Ridivex, a new corn post‑emerge herbicide

EPA-registered and planned for 2027 release; not yet for sale. Triple active ingredients (diflufenzopyr, dicamba, pyroxasulfone); fast knockdown and up to eight weeks residual.
19 October 2026

Eni completes Bouri Gas Utilization Project in Libya

Recovers previously flared associated gas; reduces emissions by ~1.5 MtCO₂/yr and supplies ~700 million Sm³/yr for domestic power and exports via GreenStream.
19 October 2026

Evonik launches Lypron® rumen-protected lysine for ruminant amino acid balancing

Delivers metabolizable lysine for precise amino-acid balancing in ruminants; supports low-protein and soy-reduced diets, is non‑GMO and made via an exclusive coating partnership.
19 October 2026

Técnicas Reunidas wins EPCM contract for Coastal GasLink Phase 2

EPCM award for Coastal GasLink Phase 2 covers detailed engineering, procurement and construction management for five compressor stations in BC; contract >€200m with 4+ year execution.
19 October 2026

AGC Biologics to develop and manufacture Flen Health enzyme therapy for diabetic foot ulcers

Process development and GMP manufacturing of lactoperoxidase and glucose oxidase to support an IND filing and a Phase II clinical trial in the US.
18 October 2026

Genentech unveils late‑stage oncology data at ESMO 2026

Late‑stage results show divarasib superiority in KRAS G12C NSCLC, giredestrant preserves quality of life while improving efficacy, and Tam‑Peli shows robust activity in nasopharyngeal carcinoma.
18 October 2026

GSK reports global phase Ib Ris‑Rez data in relapsed extensive‑stage SCLC

Phase Ib shows 61% ORR at 8 mg/kg with manageable safety; data supported selection of 8 mg/kg for the ongoing global phase III EMBOLD SCLC‑301.
16 October 2026

Johnson & Johnson: CHMP recommends TALVEY plus daratumumab for earlier-line RRMM

CHMP recommends talquetamab (TALVEY) with daratumumab ± pomalidomide for adults with relapsed/refractory multiple myeloma after ≥1 prior therapy, supported by MonumenTAL-3 efficacy and survival data.
16 October 2026

GSK presents new Ris‑Rez, Mo‑Rez and Jemperli data at ESMO 2026

More than 20 abstracts across lung, gynaecological and gastrointestinal cancers, including positive Ris‑Rez ES‑SCLC activity, Mo‑Rez durable responses in platinum‑resistant ovarian cancer, and Jemperli complete responses in MSI‑H rectal cancer.
16 October 2026

PCC SE contributes MCAA subsidiaries into PCC Rokita to consolidate chlorine & derivatives

MCAA subsidiaries valued at EUR 61.4m transferred via share swap; 4,027,312 new shares issued, raising the group's stake to 76.4% and integrating MCAA with chlorine production.
16 October 2026

Hy24 to acquire Hynamics from EDF Pulse Ventures

Agreement to transfer a low-carbon hydrogen producer active in France and the UK, targeting closing in Q1 2027 subject to regulatory approvals.
16 October 2026

Roche's Enspryng wins FDA approval for thyroid eye disease

A first‑in‑class IL‑6R inhibitor and the first and only at‑home subcutaneous treatment option for thyroid eye disease.

Next →